CRISPR Patent Fight Moves Ahead | GenomeWeb

This year may have been the CRISPR's breakout year as a technology, but the patent dispute over who owns the intellectual property for the tool is only getting underway. According to Jacob Sherkow at Stanford's Law and Biosciences Blog, a patent examiner has issued an Initial Interference Memo, paving the way for an interference proceeding.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.